Oritavancin
Back to searchMolecule Structure
Scientific Name
Oritavancin
Description of the Drug
Oritavancin is an antibacterial agent used to treat acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04911
http://www.drugbank.ca/drugs/DB04911
Brand Name(s)
Not Available
Company Owner(s)
Melinta Therapeutics Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Peptidoglycan | MACROMOLECULE | INHIBITOR | CHEMBL3041361 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL9947049 | ||
| DrugBank | DB04911 | ||
| PubChem: Thomson Pharma | 14939982 | 14915505 | |
| PubChem | 16136912 | 101991076 | |
| Nikkaji | J748.482H | ||
| BindingDB | 513037 | ||
| EPA CompTox Dashboard | DTXSID20897570 | ||
| DrugCentral | 4678 | ||
| Guide to Pharmacology | 10877 | ||
| rxnorm | ORITAVANCIN DIPHOSPHATE | ORBACTIV | ORITAVANCIN |
| KEGG Ligand | C12034 | ||
| ChEBI | 82699 |
